Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan | PNAS
Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting | Oncology
Development and validation of radiomic signatures of head and neck squamous cell carcinoma molecular features and subtypes - eBioMedicine
Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting | Oncology
Cancers | Free Full-Text | FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer | HTML
MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma - European Journal of Radiology
Frontiers | Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer | Cell and Developmental Biology
Squamous Cell Carcinoma: Biomarkers and Potential Therapeutic Targets | IntechOpen
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention - European Journal of Cancer
JCM | Free Full-Text | Deciphering the Molecular Landscape of Cutaneous Squamous Cell Carcinoma for Better Diagnosis and Treatment | HTML
The current markers of cancer stem cell in oral cancers - ScienceDirect
Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma - Baba - 2020 - Cancer Science - Wiley Online Library
Hypoxic Condition and Prognosis in Oral Squamous Cell Carcinoma | Anticancer Research
The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer
Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma - Annals of Oncology
PLOS ONE: BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated with Cisplatin- or Docetaxel-Based Chemotherapy/Chemoradiotherapy
Secreted protein markers in oral squamous cell carcinoma (OSCC) | Clinical Proteomics | Full Text
Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue | British Journal of Cancer
Table 2 from Guidelines for the Use of Tumor Markers in Cervical Cancer | Semantic Scholar
Tumor Markers in Clinical Practice: A Review Focusing on Common Solid Cancers | Semantic Scholar
Diminished CD68+ Cancer-Associated Fibroblast Subset Induces Regulatory T-Cell (Treg) Infiltration and Predicts Poor Prognosis of Oral Squamous Cell Carcinoma Patients - The American Journal of Pathology
Radiomics and radiogenomics in head and neck squamous cell carcinoma: Potential contribution to patient management and challenges - Cancer Treatment Reviews
Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies - ScienceDirect
Pre-operative cellular dissociation grading in biopsies is highly predictive of post-operative tumour stage and patient outcome in head and neck squamous cell carcinoma | British Journal of Cancer
Top ten condensed markers (CGMs) for the lung squamous cell carcinoma... | Download Table
Frontiers | Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy | Cell and Developmental Biology
Predicting Tumor Sensitivity to Chemotherapeutic Drugs in Oral Squamous Cell Carcinoma Patients | Scientific Reports
